Skip to main content
Top

29-08-2018 | Continuous glucose monitoring | Review | Article

Designing the Glucose Telemetry for Hospital Management: From Bedside to the Nursing Station

Journal: Current Diabetes Reports

Authors: Medha Satyarengga, Tariq Siddiqui, Elias K. Spanakis

Publisher: Springer US

Abstract

Purpose of the Review

Hospitalized patients with diabetes are monitored with point-of-care glucose testing. Continuous glucose monitoring (CGM) devices represent an alternative way to monitor glucose values; however, the in-hospital CGM use is still considered experimental. Most inpatient studies used “blinded” CGM properties and only few used the real-time/unblinded CGM features. One major limitation of the CGM devices is that they need to be placed at the patients’ bedside, limiting any therapeutic interventions. In this article, we review the real-time/unblinded CGM use and share our thoughts about the development of future inpatient CGM systems.

Recent Findings

We recently reported that glucose values can be wirelessly transmitted to the nursing station, providing remote continuous glucose monitoring.

Summary

Future inpatient CGM devices may be utilized for patients at risk for hypoglycemia similarly to the way that we use cardiac telemetry to monitor hospitalized patients who are at increased risk for cardiac arrhythmias.
Literature
1.
Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82. https://​doi.​org/​10.​1210/​jcem.​87.​3.​8341.CrossRefPubMed
2.
Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–9. https://​doi.​org/​10.​1136/​thx.​2005.​051029.CrossRefPubMedPubMedCentral
3.
McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810–5.CrossRefPubMed
4.
McAlister FA, Man J, Bistritz L, Amad H, Tandon P. Diabetes and coronary artery bypass surgery: an examination of perioperative glycemic control and outcomes. Diabetes Care. 2003;26(5):1518–24.CrossRefPubMed
5.
Golden SH, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care. 1999;22(9):1408–14.CrossRefPubMed
6.
• Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38. https://​doi.​org/​10.​1210/​jc.​2011-2098. An important article which summarizes the recommendations of multiple organizations about the inpatient management of hyperglycemia in the non-critical care setting CrossRefPubMed
7.
• Akirov A, Grossman A, Shochat T, Shimon I. Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related. J Clin Endocrinol Metab. 2017;102(2):416–24. https://​doi.​org/​10.​1210/​jc.​2016-2653. A recently published study which examined the association of hypoglycemia and mortality (inpatient and post-hospital discharge). CrossRefPubMed
8.
Curkendall SM, Natoli JL, Alexander CM, Nathanson BH, Haidar T, Dubois RW. Economic and clinical impact of inpatient diabetic hypoglycemia. Endocr Pract. 2009;15(4):302–12. https://​doi.​org/​10.​4158/​EP08343.​OR.CrossRefPubMed
9.
Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153–7. https://​doi.​org/​10.​2337/​dc08-2127.CrossRefPubMedPubMedCentral
10.
American Diabetes A. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–46. https://​doi.​org/​10.​2337/​dc12-2625.CrossRef
11.
American Diabetes A. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596–615. https://​doi.​org/​10.​2337/​dc08-9017.CrossRef
12.
Beck RW, Riddlesworth T, Ruedy K, Ahmann A, Bergenstal R, Haller S, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371–8. https://​doi.​org/​10.​1001/​jama.​2016.​19975.CrossRefPubMed
13.
Beck RW, Riddlesworth TD, Ruedy K, Ahmann A, Haller S, Kruger D, et al. Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial. Ann Intern Med. 2017;167(6):365–74. https://​doi.​org/​10.​7326/​M16-2855.CrossRefPubMed
14.
FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment decisions. 2016. https://​www.​fda.​gov/​newsevents/​newsroom/​pressannouncemen​ts/​ucm534056.​htm.
15.
FDA approves first continuous glucose monitoring system for adults not requiring blood sample calibration. 2017. https://​www.​fda.​gov/​NewsEvents/​Newsroom/​PressAnnouncemen​ts/​ucm577890.​htm.
16.
FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices. 2018. https://​www.​fda.​gov/​newsevents/​newsroom/​pressannouncemen​ts/​ucm602870.​htm.
17.
• Levitt DL, Silver KD, Spanakis EK. Inpatient continuous glucose monitoring and glycemic outcomes. J Diabetes Sci Technol. 2017;11(5):1028–35. https://​doi.​org/​10.​1177/​1932296817698499​. A review article which examines whether CGM devices can improve glycemic outcomes in the ICU and non-ICU setting. CrossRefPubMedPubMedCentral
18.
Klonoff DC, Buckingham B, Christiansen JS, Montori VM, Tamborlane WV, Vigersky RA, et al. Continuous glucose monitoring: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(10):2968–79. https://​doi.​org/​10.​1210/​jc.​2010-2756.CrossRefPubMed
19.
•• Wallia A, Umpierrez GE, Rushakoff RJ, Klonoff DC, Rubin DJ, Hill Golden S, et al. Consensus statement on inpatient use of continuous glucose monitoring. J Diabetes Sci Technol. 2017;11(5):1036–44. https://​doi.​org/​10.​1177/​1932296817706151​. Consensus statement about the inpatient use of Continuous Glucose Monitoring devices.CrossRefPubMedPubMedCentral
20.
• Preiser JC, Chase JG, Hovorka R, Joseph JI, Krinsley JS, De Block C, et al. Glucose control in the ICU: a continuing story. J Diabetes Sci Technol. 2016;10(6):1372–81. https://​doi.​org/​10.​1177/​1932296816648713​. A review article which examines the role of CGM devices in the ICU setting. CrossRefPubMedPubMedCentral
21.
•• Spanakis EK, Levitt DL, Siddiqui T, Singh LG, Pinault L, Sorkin J, et al. The effect of continuous glucose monitoring in preventing inpatient hypoglycemia in general wards: the glucose telemetry system. J Diabetes Sci Technol. 2018;12(1):20–5. https://​doi.​org/​10.​1177/​1932296817748964​. A pilot study which showed that glucose values can be wirelessly transmitted to the nursing station, creating a remote Continuous Glucose Monitoring system, similar to the cardiac telemetry concept. CrossRefPubMed
22.
Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Botz CK, Zingg W, et al. Clinical control of diabetes by the artificial pancreas. Diabetes. 1974;23(5):397–404.CrossRefPubMed
23.
Gomez AM, Umpierrez GE. Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol. 2014;8(5):930–6. https://​doi.​org/​10.​1177/​1932296814546025​.CrossRefPubMedPubMedCentral
24.
Damiano ER, El-Khatib FH, Zheng H, Nathan DM, Russell SJ. A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care. 2013;36(2):251–9. https://​doi.​org/​10.​2337/​dc12-0070.CrossRefPubMedPubMedCentral
25.
Bochicchio GV, Nasraway S, Moore L, Furnary A, Nohra E, Bochicchio K. Results of a multicenter prospective pivotal trial of the first inline continuous glucose monitor in critically ill patients. J Trauma Acute Care Surg. 2017;82(6):1049–54. https://​doi.​org/​10.​1097/​TA.​0000000000001444​.CrossRefPubMed
26.
Kosiborod M, Gottlieb RK, Sekella JA, Peterman D, Grodzinsky A, Kennedy P, et al. Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit. BMJ Open Diabetes Res Care. 2014;2(1):e000037. https://​doi.​org/​10.​1136/​bmjdrc-2014-000037.CrossRefPubMedPubMedCentral
27.
De Block CE, Gios J, Verheyen N, Manuel-y-Keenoy B, Rogiers P, Jorens PG, et al. Randomized evaluation of glycemic control in the medical intensive care unit using real-time continuous glucose monitoring (REGIMEN trial). Diabetes Technol Ther. 2015;17(12):889–98. https://​doi.​org/​10.​1089/​dia.​2015.​0151.CrossRefPubMed
28.
Foubert LA, Lecomte PV, Nobels FR, Gulino AM, De Decker KH. Accuracy of a feasibility version of an intravenous continuous glucose monitor in volunteers with diabetes and hospitalized patients. Diabetes Technol Ther. 2014;16(12):858–66. https://​doi.​org/​10.​1089/​dia.​2014.​0082.CrossRefPubMed
29.
Crane BC, Barwell NP, Gopal P, Gopichand M, Higgs T, James TD, et al. The development of a continuous intravascular glucose monitoring sensor. J Diabetes Sci Technol. 2015;9(4):751–61. https://​doi.​org/​10.​1177/​1932296815587937​.CrossRefPubMedPubMedCentral
30.
Schierenbeck F, Owall A, Franco-Cereceda A, Liska J. Evaluation of a continuous blood glucose monitoring system using a central venous catheter with an integrated microdialysis function. Diabetes Technol Ther. 2013;15(1):26–31. https://​doi.​org/​10.​1089/​dia.​2012.​0169.CrossRefPubMed
31.
McDonnell ME, Umpierrez GE. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin N Am. 2012;41(1):175–201. https://​doi.​org/​10.​1016/​j.​ecl.​2012.​01.​001.CrossRef
32.
van Steen SC, Rijkenberg S, Limpens J, van der Voort PH, Hermanides J, DeVries JH. The clinical benefits and accuracy of continuous glucose monitoring systems in critically Ill patients—a systematic scoping review. Sensors (Basel). 2017;17(1) https://​doi.​org/​10.​3390/​s17010146.CrossRefPubMedCentral
33.
Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41:1579–89. https://​doi.​org/​10.​2337/​dci18-0002.CrossRefPubMedPubMedCentral
34.
Logtenberg SJ, Kleefstra N, Snellen FT, Groenier KH, Slingerland RJ, Nierich AP, et al. Pre- and postoperative accuracy and safety of a real-time continuous glucose monitoring system in cardiac surgical patients: a randomized pilot study. Diabetes Technol Ther. 2009;11(1):31–7. https://​doi.​org/​10.​1089/​dia.​2008.​0028.CrossRefPubMed
35.
•• Holzinger U, Warszawska J, Kitzberger R, Wewalka M, Miehsler W, Herkner H, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial. Diabetes Care. 2010;33(3):467–72. https://​doi.​org/​10.​2337/​dc09-1352. A randomized control trial in the ICU setting that showed that RT-CGM can decrease severe hypoglycemia CrossRefPubMed
36.
Rabiee A, Andreasik V, Abu-Hamdah R, Galiatsatos P, Khouri Z, Gibson BR, et al. Numerical and clinical accuracy of a continuous glucose monitoring system during intravenous insulin therapy in the surgical and burn intensive care units. J Diabetes Sci Technol. 2009;3(4):951–9.CrossRefPubMedPubMedCentral
37.
Kopecky P, Mraz M, Blaha J, Lindner J, Svacina S, Hovorka R, et al. The use of continuous glucose monitoring combined with computer-based eMPC algorithm for tight glucose control in cardiosurgical ICU. Biomed Res Int. 2013;2013:186439–8. https://​doi.​org/​10.​1155/​2013/​186439.CrossRefPubMedPubMedCentral
38.
Rodriguez-Quintanilla KA, Lavalle-Gonzalez FJ, Mancillas-Adame LG, Zapata-Garrido AJ, Villarreal-Perez JZ, Tamez-Perez HE. Continuous glucose monitoring in acute coronary syndrome. Arch Cardiol Mex. 2013;83(4):237–43. https://​doi.​org/​10.​1016/​j.​acmx.​2013.​08.​001.CrossRefPubMed
39.
•• Boom DT, Sechterberger MK, Rijkenberg S, Kreder S, Bosman RJ, Wester JP, et al. Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care. 2014;18(4):453. https://​doi.​org/​10.​1186/​s13054-014-0453-9. A randomized control trial in the ICU setting that showed that RT-CGM did not improve glycemic control, although nursing workload was decreased by 53%. CrossRefPubMedPubMedCentral
40.
van Hooijdonk RT, Leopold JH, Winters T, Binnekade JM, Juffermans NP, Horn J, et al. Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study. Crit Care. 2015;19:34. https://​doi.​org/​10.​1186/​s13054-015-0757-4.CrossRefPubMedPubMedCentral
41.
Gottschalk A, Welp HA, Leser L, Lanckohr C, Wempe C, Ellger B. Continuous glucose monitoring in patients undergoing extracorporeal ventricular assist therapy. PLoS One. 2016;11(3):e0148778. https://​doi.​org/​10.​1371/​journal.​pone.​0148778.CrossRefPubMedPubMedCentral
42.
Umbrello M, Salice V, Spanu P, Formenti P, Barassi A, Melzi d'Eril GV, et al. Performance assessment of a glucose control protocol in septic patients with an automated intermittent plasma glucose monitoring device. Clin Nutr. 2014;33(5):867–71. https://​doi.​org/​10.​1016/​j.​clnu.​2013.​10.​007.CrossRefPubMed
43.
Wollersheim T, Engelhardt LJ, Pachulla J, Moergeli R, Koch S, Spies C, et al. Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial. Ann Intensive Care. 2016;6(1):70. https://​doi.​org/​10.​1186/​s13613-016-0167-z.CrossRefPubMedPubMedCentral
44.
Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook J. Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010;4(3):636–44. https://​doi.​org/​10.​1177/​1932296810004003​18.CrossRefPubMedPubMedCentral
45.
Burt MG, Roberts GW, Aguilar-Loza NR, Stranks SN. Brief report: comparison of continuous glucose monitoring and finger-prick blood glucose levels in hospitalized patients administered basal-bolus insulin. Diabetes Technol Ther. 2013;15(3):241–5. https://​doi.​org/​10.​1089/​dia.​2012.​0282.CrossRefPubMed
46.
•• Schaupp L, Donsa K, Neubauer KM, Mader JK, Aberer F, Holl B, et al. Taking a closer look--continuous glucose monitoring in non-critically ill hospitalized patients with type 2 diabetes mellitus under basal-bolus insulin therapy. Diabetes Technol Ther. 2015;17(9):611–8. https://​doi.​org/​10.​1089/​dia.​2014.​0343. A study in the non-ICU setting which showed that blinded CGM were more likely to detect hypoglycemia than POC glucose testing. CrossRefPubMed
47.
•• Gomez AM, Umpierrez GE, Munoz OM, Herrera F, Rubio C, Aschner P, et al. Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol. 2015;10(2):325–9. https://​doi.​org/​10.​1177/​1932296815602905​. A study in the non-ICU setting which showed that blinded CGM were more likely to detect hypoglycemia than POC glucose testing. CrossRefPubMedPubMedCentral
48.
Levitt DL, Silver KD, Spanakis EK. Mitigating severe hypoglycemia by initiating inpatient continuous glucose monitoring for type 1 diabetes mellitus. J Diabetes Sci Technol. 2017;11(2):440–1. https://​doi.​org/​10.​1177/​1932296816664538​.CrossRefPubMedPubMedCentral
49.
Strasma PJ, Finfer S, Flower O, Hipszer B, Kosiborod M, Macken L, et al. Use of an intravascular fluorescent continuous glucose sensor in ICU patients. J Diabetes Sci Technol. 2015;9(4):762–70. https://​doi.​org/​10.​1177/​1932296815585872​.CrossRefPubMedPubMedCentral
50.
Dexcom G6 Continuous Glucose Monitoring System. 2018. https://​www.​dexcom.​com/​safety-information.

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »